国家自然科学基金资助心血管领域微小RNA相关研究的概况与分析
被引量:5
摘要
该文精确地概括了国家自然科学基金委员会10年来对心血管领域微小RNA(miRNA)的资助项目,一方面反映了我国该领域研究的基本状况,另一方面也概括了其前沿。对广大心血管医生及研究人员都有很大的参考和借鉴价值。
出处
《中华心血管病杂志》
CAS
CSCD
北大核心
2013年第5期357-362,共6页
Chinese Journal of Cardiology
参考文献84
-
1Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993,75:843-854.
-
2Boon RA, Vickers KC. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol, 2013, 33: 186-192.
-
3Fernandez-Hernando C, R.amirez CM, Goedeke L, et al. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol, 2013,33 : 178-185.
-
4Dang LT, Lawson ND, Fish JE. MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol,2013,33 : 193-200,.
-
5Fiedler J, Thum T. MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Biol,2013 ,33 :201-205.
-
6Mayr M, Zampetaki A, Willeit P, et al. MicroRNAs within the continuum of postgenomics biomarker discovery. Arterioscler Thromb Vasc Biol,2013,33:206-214.
-
7Weber C. MicroRNAs: from basic mechanisms to clinical application in cardiovascular medicine. Arterioscler Thromb Vasc Biol,2013 ,33 :168-169.
-
8Albinsson S, Suarez Y, Skoura A, et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Artefioscler Thromb V asc Biol,2010,30 : 1118-1126.
-
9Cheu JF, Murehison EP, Tang R, et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A,2008,105:2111-2116.
-
10Ivey KN, Muth A, Anaold J, et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell, 2008,2:219-229.
同被引文献55
-
1Lewis BP, Burge CB, Barrel DP. Conserved seed pairing, often flanked by adeno- sines,indicates that thousands of human genes are microRNA targets[ J ]. Cell, 2005,120 : 15-20.
-
2Grey F, Tirabassi R, Meyers H,et al. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs [ J ]. PLoS Pathog, 2010, 6 (6) : e1000967.
-
3Ono K,Kuwabara Y,Han J. Mof NAs and cardiovascular diseases[ J ]. FEBS J,2011,278(10) :1619-1633.
-
4Chen CZ. An unsolved mystery: the target-recognizlng RNA species of microRNA genes [ J ]. Biochimie,2013,95 ( 9 ) : 1663 -1676.
-
5Liu N, Bezprozvannaya S,Williams AH,et al, MicroRNA-133a regulates cardio- myocyte prtliferation and suppresses smooth muscle geue expression in the heart [ J ]. Genes Dev, 2008,22 ( 23 ) : 3242-3254.
-
6Schneider M, Andeen DC, Silahtaroglu A, et al. Cell-specific detection of mi- croRNA expression during cardiomyogenesis by combined in situ hybridization and i mmunohistochemistry [ J ]. J Mol Histo1,2011,42 (4) : 289-299.
-
7van Rooij E, Marshall WS, Olson EN. Toward miemRNA based therapeutics for h eart disease : the sense in antisense [ J ]. Circ Res, 2008,103 ( 9 ) : 919 -928.
-
8Thum T,Gross C, Fiedler J, et al. MiroRNA-21 contributes to myocardial dis- ease by stimulating MAP kinase signalling in fibroblasts [ J ]. Nature,2008,456 (7224) :980-984.
-
9Ivey KN, Mutb A, Arnold J.et al. MieroRNA regulalion of cell lineages in mouse and human embryonic: stem cells [ J ]. Cell Stem Ce11,2008,2 ( 3 ) :219 -229.
-
10Cari A,Catducci D, Felicetti F,et al. MicroRNA-133 controls cardia hypertro- phy[J]. Nat Med,2007,13(5) :613-618.
引证文献5
-
1杜银苹,李东野.微小RNA在心血管疾病中的研究进展[J].中华临床医师杂志(电子版),2014,8(7):100-104. 被引量:12
-
2吴伟东,易永盛,周洋洋.microRNA在心力衰竭病理变化过程中的调节意义[J].心血管病学进展,2016,37(5):554-558. 被引量:4
-
3林德洪,钟江华,郑颖,张忆雪.miRNA-1在高血压左心室肥厚诊断中的价值[J].临床心血管病杂志,2017,33(10):962-965. 被引量:5
-
4朱邦,陈如昌,朱晓丹.急性肺栓塞患者血清miRNAs标志物检测及miR-134的临床价值[J].全科医学临床与教育,2018,16(6):617-620. 被引量:3
-
5李志勇,张卫.miRNAs在心血管疾病中的研究进展[J].中华心脏与心律电子杂志,2016,4(4). 被引量:2
二级引证文献26
-
1于水澜,于英君,王桂云,宋高臣.miRNA与疾病相关性研究进展[J].牡丹江医学院学报,2015,36(1):94-96. 被引量:4
-
2杨寿娟,张颖,刘寅.冠心病患者外周血中miRNA-21的表达水平及其临床意义[J].中国应用生理学杂志,2015,31(2):127-131. 被引量:14
-
3吴晓燕,商洪才,苗琳,樊官伟.微小RNA与炎症相关心血管疾病的研究进展[J].中国心血管杂志,2015,20(4):317-320.
-
4赵艳,李欣彤,李鹏.心血管衰老与microRNAs相关性研究进展[J].新疆中医药,2016,34(2):105-109. 被引量:2
-
5黄守清,许艺惠,尹莲花.血管内皮细胞miRNAs与高血压病血瘀证的相关性研究进展[J].医学综述,2016,22(11):2085-2088. 被引量:9
-
6谢佳,张雷.早期心肌缺血猝死患者心肌干细胞及高迁移率族蛋白1、miRNA-206表达的变化[J].中华细胞与干细胞杂志(电子版),2016,6(3):155-159. 被引量:4
-
7黄振华,叶子,蒋鹏,肖孝勇,李茜,詹红.miRNAs在急性心肌梗死诊断中的研究进展[J].岭南心血管病杂志,2017,23(3):347-350. 被引量:6
-
8曹蛟,刘文奇,杨晓航,彭玉琴.微小RNA(miRNA)在溃疡性结肠炎研究及中医治疗中的应用[J].山东中医杂志,2017,36(10):902-905. 被引量:4
-
9张涛,姚亚丽.硫化氢与microRNA在心力衰竭中的作用[J].心血管病学进展,2018,39(4):626-629.
-
10周红,董莉.miRNA在自体细胞移植治疗扩张型心肌病的意义[J].现代检验医学杂志,2018,33(5):155-156. 被引量:1
-
1李健和,许树梧,张卓容.对乙酰氨基酚制剂研究的概况[J].药学情报通讯,1993,11(4):34-37. 被引量:1
-
2李健和,陈孝治,吴世良.喹诺酮类制剂研究的概况[J].中国医院药学杂志,1993,13(4):177-179. 被引量:9
-
3彭晖节.现代药物研究的概况和前景[J].天津药学,1994,6(1):57-58.
-
4陆荣柱,金锡鹏,顾学箕.对二氯苯毒性研究的概况[J].中国公共卫生,1995,11(9):428-430. 被引量:10
-
5姚焕英.多肽药物的研究及应用进展[J].陕西师范大学学报(自然科学版),2002,30(S1):131-134. 被引量:1
-
6杜海洲,宋金燕,姚春芳.国际上抗癌新药研究的概况[J].药学服务与研究,2006,6(3):186-192. 被引量:3
-
7岑彦艳,魏泓.小型猪用于药物代谢研究的概况[J].解放军药学学报,2007,23(4):294-296. 被引量:2
-
8秦国伟.越南药用植物化学研究的概况[J].国外医药(植物药分册),1995,10(4):157-158.
-
9谢红光,周宏灏.异喹胍型遗传多态性研究的概况[J].湖南医学,1993,10(5):290-292.
-
10吴旭.蜕皮激素医学研究的概况[J].战创伤参考资料,1997,26(4):15-18. 被引量:1